FDA: Blood Pressure Medication Warning
The U.S. Food and Drug Administration (FDA) is warning of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors ( ACEIs ) and angiotensin receptor blockers ( ARBs ) in patients with diabetes or kidney (renal) impairment.
Classes for Your Kidney Transplant
Certain populations, such as African Americans, are less likely than whites to get a kidney transplant when they need it. This may be happening because patients do not know about the entire transplant process.
FDA Drug Safety Communication: Reclast
The U.S. Food and Drug Administration (FDA) has approved an update to the drug label for Reclast ( zoledronic acid) to better inform healthcare professionals and patients of the risk of kidney (renal) failure.
Don't Hate on Peritoneal Dialysis
Patients with end-stage renal disease who choose to undergo peritoneal dialysis have no greater risk of catheter infection than those who go through hemodialysis.
Keep Me Informed, Please
A recent survey reveals that many patients with end-stage renal disease (ESRD) want more information on the various treatment options available to them.
A Plan to Help the Pre-existing Condition Crowd
The U.S. Department of Health and Human Services (HHS) is increasing awareness about a health plan for uninsured Americans with pre-existing conditions created by the Affordable Care Act.
Kidneys on the Move
Johns Hopkins researchers have found that kidneys shipped on ice for transplant are just as safe and effective as kidneys that come from donors in the same hospital where the transplant operation takes place.